scholarly journals NPCMF: Nearest Profile-based Collaborative Matrix Factorization method for predicting miRNA-disease associations

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Ying-Lian Gao ◽  
Zhen Cui ◽  
Jin-Xing Liu ◽  
Juan Wang ◽  
Chun-Hou Zheng
Keyword(s):  
Matrix Factorization ◽  
Factorization Method ◽  
Disease Associations

scholarly journals Bipartite graph-based collaborative matrix factorization method for predicting miRNA-disease associations

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Feng Zhou ◽  
Meng-Meng Yin ◽  
Cui-Na Jiao ◽  
Zhen Cui ◽  
Jing-Xiu Zhao ◽  
...  
Keyword(s):  
Bipartite Graph ◽  
Matrix Factorization ◽  
Cross Validation ◽  
Rapid Development ◽  
Factorization Method ◽  
Computational Method ◽  
Human Diseases ◽  
Simulation Experiments ◽  
Disease Associations ◽  
Fold Cross Validation

Abstract Background With the rapid development of various advanced biotechnologies, researchers in related fields have realized that microRNAs (miRNAs) play critical roles in many serious human diseases. However, experimental identification of new miRNA–disease associations (MDAs) is expensive and time-consuming. Practitioners have shown growing interest in methods for predicting potential MDAs. In recent years, an increasing number of computational methods for predicting novel MDAs have been developed, making a huge contribution to the research of human diseases and saving considerable time. In this paper, we proposed an efficient computational method, named bipartite graph-based collaborative matrix factorization (BGCMF), which is highly advantageous for predicting novel MDAs. Results By combining two improved recommendation methods, a new model for predicting MDAs is generated. Based on the idea that some new miRNAs and diseases do not have any associations, we adopt the bipartite graph based on the collaborative matrix factorization method to complete the prediction. The BGCMF achieves a desirable result, with AUC of up to 0.9514 ± (0.0007) in the five-fold cross-validation experiments. Conclusions Five-fold cross-validation is used to evaluate the capabilities of our method. Simulation experiments are implemented to predict new MDAs. More importantly, the AUC value of our method is higher than those of some state-of-the-art methods. Finally, many associations between new miRNAs and new diseases are successfully predicted by performing simulation experiments, indicating that BGCMF is a useful method to predict more potential miRNAs with roles in various diseases.

scholarly journals MCCMF: collaborative matrix factorization based on matrix completion for predicting miRNA-disease associations

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Tian-Ru Wu ◽  
Meng-Meng Yin ◽  
Cui-Na Jiao ◽  
Ying-Lian Gao ◽  
Xiang-Zhen Kong ◽  
...  
Keyword(s):  
Matrix Factorization ◽  
Cross Validation ◽  
Matrix Completion ◽  
Factorization Method ◽  
Similarity Matrix ◽  
Validation Experiment ◽  
Disease Associations ◽  
Auc Value ◽  
Regulatory Functions ◽  
Association Matrix

Abstract Background MicroRNAs (miRNAs) are non-coding RNAs with regulatory functions. Many studies have shown that miRNAs are closely associated with human diseases. Among the methods to explore the relationship between the miRNA and the disease, traditional methods are time-consuming and the accuracy needs to be improved. In view of the shortcoming of previous models, a method, collaborative matrix factorization based on matrix completion (MCCMF) is proposed to predict the unknown miRNA-disease associations. Results The complete matrix of the miRNA and the disease is obtained by matrix completion. Moreover, Gaussian Interaction Profile kernel is added to the miRNA functional similarity matrix and the disease semantic similarity matrix. Then the Weight K Nearest Known Neighbors method is used to pretreat the association matrix, so the model is close to the reality. Finally, collaborative matrix factorization method is applied to obtain the prediction results. Therefore, the MCCMF obtains a satisfactory result in the fivefold cross-validation, with an AUC of 0.9569 (0.0005). Conclusions The AUC value of MCCMF is higher than other advanced methods in the fivefold cross validation experiment. In order to comprehensively evaluate the performance of MCCMF, accuracy, precision, recall and f-measure are also added. The final experimental results demonstrate that MCCMF outperforms other methods in predicting miRNA-disease associations. In the end, the effectiveness and practicability of MCCMF are further verified by researching three specific diseases.

scholarly journals DSCMF: prediction of LncRNA-disease associations based on dual sparse collaborative matrix factorization

2021 ◽  
Vol 22 (S3) ◽  
Author(s):  
Jin-Xing Liu ◽  
Ming-Ming Gao ◽  
Zhen Cui ◽  
Ying-Lian Gao ◽  
Feng Li
Keyword(s):  
Matrix Factorization ◽  
Factorization Method ◽  
Treatment And Prevention ◽  
Cancer Breast ◽  
Disease Associations ◽  
Network Similarity ◽  
Huge Impact ◽  
Auc Value ◽  
Fold Cross Validation

Abstract Background In the development of science and technology, there are increasing evidences that there are some associations between lncRNAs and human diseases. Therefore, finding these associations between them will have a huge impact on our treatment and prevention of some diseases. However, the process of finding the associations between them is very difficult and requires a lot of time and effort. Therefore, it is particularly important to find some good methods for predicting lncRNA-disease associations (LDAs). Results In this paper, we propose a method based on dual sparse collaborative matrix factorization (DSCMF) to predict LDAs. The DSCMF method is improved on the traditional collaborative matrix factorization method. To increase the sparsity, the L2,1-norm is added in our method. At the same time, Gaussian interaction profile kernel is added to our method, which increase the network similarity between lncRNA and disease. Finally, the AUC value obtained by the experiment is used to evaluate the quality of our method, and the AUC value is obtained by the ten-fold cross-validation method. Conclusions The AUC value obtained by the DSCMF method is 0.8523. At the end of the paper, simulation experiment is carried out, and the experimental results of prostate cancer, breast cancer, ovarian cancer and colorectal cancer are analyzed in detail. The DSCMF method is expected to bring some help to lncRNA-disease associations research. The code can access the https://github.com/Ming-0113/DSCMF website.

scholarly journals RCMF: a robust collaborative matrix factorization method to predict miRNA-disease associations

2019 ◽  
Vol 20 (S25) ◽  
Author(s):  
Zhen Cui ◽  
Jin-Xing Liu ◽  
Ying-Lian Gao ◽  
Chun-Hou Zheng ◽  
Juan Wang
Keyword(s):  
Matrix Factorization ◽  
Factorization Method ◽  
Simulation Experiments ◽  
Gold Standard Dataset ◽  
Disease Associations ◽  
Auc Value ◽  
Accuracy Of Prediction ◽  
Fold Cross Validation ◽  
Novel Associations ◽  
Better Than

Abstract Background Predicting miRNA-disease associations (MDAs) is time-consuming and expensive. It is imminent to improve the accuracy of prediction results. So it is crucial to develop a novel computing technology to predict new MDAs. Although some existing methods can effectively predict novel MDAs, there are still some shortcomings. Especially when the disease matrix is processed, its sparsity is an important factor affecting the final results. Results A robust collaborative matrix factorization (RCMF) is proposed to predict novel MDAs. The L2,1-norm are introduced to our method to achieve the highest AUC value than other advanced methods. Conclusions 5-fold cross validation is used to evaluate our method, and simulation experiments are used to predict novel associations on Gold Standard Dataset. Finally, our prediction accuracy is better than other existing advanced methods. Therefore, our approach is effective and feasible in predicting novel MDAs.

scholarly journals Lossless Linear Integer signal Resampling

2012 ◽  
pp. 225-233
Author(s):  
S.Raghavendra Prasad ◽  
Dr.P.Ramana Reddy
Keyword(s):  
Matrix Factorization ◽  
High Frequency ◽  
Irreversible Process ◽  
Polynomial Interpolation ◽  
Factorization Method ◽  
Special Cases ◽  
The Matrix ◽  
Frequency Components ◽  
Linear Transform ◽  
Signal Resampling

This paper describes about signal resampling based on polynomial interpolation is reversible for all types of signals, i.e., the original signal can be reconstructed losslessly from the resampled data. This paper also discusses Matrix factorization method for reversible uniform shifted resampling and uniform scaled and shifted resampling. Generally, signal resampling is considered to be irreversible process except in some special cases because of strong attenuation of high frequency components. The matrix factorization method is actually a new way to compute linear transform. The factorization yields three elementary integer-reversible matrices. This method is actually a lossless integer-reversible implementation of linear transform. Some examples of lower order resampling solutions are also presented in this paper.

Sign in / Sign up

Export Citation Format

Share Document